SLNO Soleno Therapeutics delivers 103 percent Q4 2025 EPS beat notches small intraday share gains IBO Impact BioMedical quarterly earnings report shows no revenue or EPS data disclosed investors await additional details What Primoris PRIM management is not saying enough about 667 20260508 Invesco Optimum Yield Diversified Commodity Strategy No K1 ETF PDBC 35 YTD Rally Masks High Uncertainty in 2026 December Distribution Profile